Does Topical Retinoic Acid Affect Early Pregnancy and Fetal Development?

Will the use of topical retinoic acid affect the fetus during early pregnancy?

Topical retinoic acid (A acid) may have potential effects on a developing fetus during early pregnancy.
It is generally advised that pregnant women avoid using retinoids due to the risk of teratogenic effects.
Regarding the medication classifications for pregnant women:
1.
Mylanta - This is typically classified as Category B, meaning it is generally considered safe during pregnancy.
2.
Scanol (500mg) - The classification may vary depending on the specific formulation, so it is important to consult a healthcare provider for accurate information.
3.
BECOLON - The classification for this medication is also dependent on its specific components and should be verified with a healthcare professional.
4.
MEDICON-A - This medication's classification should be confirmed with a healthcare provider as well.
Always consult a healthcare professional before taking any medication during pregnancy.

meimei, 30~39 year old female. Ask Date: 2005/05/04

Dr. Wu Huiling reply Pharmacology

Hello! The medication classification for pregnant women is based on the pregnancy and embryotoxicity categories established by the U.S.
Food and Drug Administration (FDA):
Category A: Controlled studies in pregnant women during the first trimester (the first three months) have shown that the drug is not harmful to the fetus, and there is no evidence of risk in the later trimesters of pregnancy.

Category B: Animal reproduction studies have not demonstrated any embryotoxicity, but there are no adequate and well-controlled studies in pregnant women; or animal reproduction studies have shown adverse effects (greater than a decrease in fertility), but controlled studies in pregnant women have not demonstrated any embryotoxicity.

Category C: Animal studies have shown adverse effects on the embryo (teratogenic or embryotoxic effects or others), but there are no adequate studies in pregnant women; or there are no controlled studies in pregnant women or animals.
This drug should only be used if the potential benefits outweigh the potential risks.

Category D: There is evidence of human fetal risk based on adverse reaction data, but the potential benefits of the drug may outweigh the risks in certain situations, allowing for its use in pregnant women despite the risks.

Category X: Studies in both animals and humans have demonstrated fetal abnormalities, and the risks of using this drug in pregnant women far outweigh any potential benefits, making it contraindicated for use in pregnant or potentially pregnant women.

Topical retinoids, such as tretinoin, are classified as Category C and are not recommended for use in pregnant women, as they have been associated with delayed skeletal development in some animal embryos.
Mylanta has not been established in either animal or human studies for use during pregnancy, but some reports suggest that long-term and high-dose use of antacids during pregnancy may cause adverse effects in the fetus; therefore, sodium-containing antacids should be avoided in cases of fluid retention.

Scanol is classified as Category B; although no studies have been conducted in pregnant women, there are no reports of teratogenic issues.
Becolon is classified as Category C and should only be used when prescribed by a physician after assessing that the benefits outweigh the risks.
The pregnancy category for Medicon A has not been established.

In summary, it is advised that women who are pregnant or may become pregnant should avoid the misuse of over-the-counter medications.
If any discomfort arises, they should consult their family physician to establish a complete medical history and medication record to ensure medical safety.

Reply Date: 2005/05/04

More Info

Topical retinoic acid, commonly known as tretinoin, is a derivative of vitamin A and is often used in dermatology for the treatment of acne and other skin conditions. When considering its use during early pregnancy, it is crucial to understand the potential implications for fetal development.

The primary concern with retinoids, including topical retinoic acid, is their association with teratogenic effects when used during pregnancy. Teratogenicity refers to the ability of a substance to cause developmental malformations in a fetus. While systemic retinoids (like isotretinoin) have well-documented risks of causing severe birth defects, the risk associated with topical retinoids is less clear.
According to the FDA pregnancy category system, topical retinoic acid is classified as Category C. This classification indicates that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in pregnant women. Therefore, the use of topical retinoic acid during pregnancy should be approached with caution. Although the systemic absorption of topical retinoids is significantly lower than that of oral retinoids, there is still a potential risk, especially during the first trimester when the fetus is most vulnerable to teratogenic agents.

Regarding the specific medications you mentioned—Mylanta, Scanol, and Becolon—let's break down their classifications:
1. Mylanta: This is an antacid that contains aluminum hydroxide, magnesium hydroxide, and simethicone. It is generally considered safe during pregnancy, but long-term use or high doses should be avoided due to potential risks such as fluid retention.

2. Scanol: This medication is classified as Category B, meaning that there are no proven risks in human studies, and it has not shown any adverse effects in animal studies. Therefore, it is generally considered safe for use during pregnancy.

3. Becolon: This medication falls under Category C, indicating that animal studies have shown adverse effects, but there are no adequate studies in humans. It should only be used if the potential benefits outweigh the risks.

In summary, while topical retinoic acid poses some risk during early pregnancy, the extent of that risk is not fully understood. It is advisable for pregnant women or those planning to become pregnant to avoid using topical retinoids unless specifically directed by a healthcare provider. If you are currently using topical retinoic acid and find out you are pregnant, it is essential to consult your healthcare provider immediately for guidance on how to proceed.

Additionally, if you are considering pregnancy, it is wise to discuss your current medications with your healthcare provider to evaluate their safety and explore alternative treatments if necessary. Always prioritize open communication with your healthcare team to ensure the best outcomes for both you and your future child.

Similar Q&A

Impact of Topical Retinoids During Pregnancy: Risks and Concerns

I am 16 weeks pregnant now, but during the early stages, I had acne and used a third-generation moisturizer that contains retinoids on my face for about two months. Later, I heard that it could affect the baby and cause birth defects, so I stopped using it at 13 weeks. Will this ...

Dr. Chen Changfu reply Obstetrics and Gynecology
Dear netizens: Hello! Most topical medications for skin treatment are absorbed into the body in very small amounts. Currently, there are no reports or warnings in obstetric clinical practice indicating that moisturizing creams cause fetal malformations, so the likelihood of affec...

Does Vitamin A Ester in Skincare Affect Fetal Development?

Hello Dr. Tsao: I am currently almost six months pregnant. I have been using a facial mask called "My Beauty Diary Purifying Pore Mask" since the early stages of my pregnancy. I have always been careful to check for the presence of retinoids in my skincare products, but...

Dr. Cao Guotao reply Obstetrics and Gynecology
Hello, it generally does not have an impact; just monitor it. Wishing you good health.

Is Vitamin A Safe During Pregnancy? Concerns About Retinol Use

Hello, doctor! I am currently 30 weeks pregnant. I was aware that it is best to avoid skincare products containing retinoids during pregnancy, but I did not realize that vitamin A is also harmful to the fetus. I recently discovered that the eye cream I have been using daily conta...

Dr. Lü Lizheng reply Obstetrics and Gynecology
The eye cream contains vitamin A (retinol), which is generally absorbed very little into the body. Therefore, it should not lead to an overdose. A small amount of vitamin A (retinol) is unlikely to have any impact on the fetus. Sincerely, Lu Li Zheng.

Impact of Topical Retinoids and Steroid Nasal Sprays on Pregnancy

Hello, Doctor: My husband and I are currently trying to conceive. For the past few months, my husband has been applying a first-generation retinoid (Tretinoin cream) prescribed by a dermatologist every day. I have also been using a nasal spray (Azelastine) containing a steroid da...

Dr. Cao Guotao reply Obstetrics and Gynecology
Hello, topical application has minimal impact. Wishing you good health.